Literature DB >> 11734742

International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection.

M Frühwirth1, U Heininger, B Ehlken, G Petersen, B Laubereau, I Moll-Schüler, I Mutz, J Forster.   

Abstract

BACKGROUND: The great impact of rotavirus disease on morbidity and medical health care costs in industrialized countries together with the withdrawal of the live oral rotavirus vaccine have made a reassessment of rotavirus gastroenteritis necessary. Such a reassessment should provide sufficient data for developing alternative disease prevention strategies and for allocating resources efficiently.
OBJECTIVES: To compare characteristics and management of community- and nosocomially acquired rotavirus disease in Austria, Germany and Switzerland. PATIENTS AND METHODS: In a prospective, population-based, trinational (Austria, Germany, Switzerland), multicenter (9 cities, 10 hospitals and 30 pediatric practices) study, a total of 174 552 children months and 78 516 hospital days were evaluated. Participants were all children 4 years of age and younger, who either presented at one of the pediatric practices with community-acquired gastroenteritis, or who had acquired gastroenteritis nosocomially. From December, 1997, to May, 1998, prospective antigen testing was done by enzyme-linked immunosorbent assay, and serotyping was done by reverse transcription polymerase chain reaction. Disease severity was scored by the Vesikari severity scale.
RESULTS: Rotavirus was detected in 29.5, 27 and 37.5% of children with community-acquired gastroenteritis and in 57, 69 and 49% of children with nosocomial gastroenteritis in Austria, Germany and Switzerland, respectively. Severity of community-acquired rotavirus gastroenteritis was more pronounced in Austria (median severity score, 11) than in Germany (median score, 9) or Switzerland (median score, 10). However, only 2% of Austrian and Swiss children compared with 12% of German children presented to their pediatricians more than four times. Nosocomially acquired rotavirus gastroenteritis was mildest in Austria but occurred within the shortest median duration of hospitalization (4 days vs. 5 and 7 in Germany and Switzerland, respectively). In a multivariant analysis age, family size, day care, breast-feeding and nationality were not predictive factors for enhanced risk to contract rotavirus infection. Alimentation was changed frequently; diet was used between 23 and 83%; special formulas were used between 10 and 57%.
CONCLUSION: The cumulative experience from three European countries suggest that rotavirus is an important cause of diarrhea in Central Europe, but significant local differences clearly demonstrate the need for obtaining national data as a reliable basis for control and prevention of the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11734742     DOI: 10.1097/00006454-200108000-00013

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  21 in total

Review 1.  The paediatric burden of rotavirus disease in Europe.

Authors: 
Journal:  Epidemiol Infect       Date:  2006-04-04       Impact factor: 2.451

2.  Active hospital-based surveillance of rotavirus diarrhea in Austrian children, period 1997 to 2003.

Authors:  Pamela Rendi-Wagner; Michael Kundi; Andrea Mikolasek; Ingomar Mutz; Karl Zwiauer; Ursula Wiedermann; Andreas Vécsei; Herwig Kollaritsch
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

Review 3.  Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Authors:  Keith Grimwood; Stephen B Lambert; Richard J Milne
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

4.  Infantile gastroenteritis in the community: a cost-of-illness study.

Authors:  P K Lorgelly; D Joshi; M Iturriza Gómara; C Flood; C A Hughes; J Dalrymple; J Gray; M Mugford
Journal:  Epidemiol Infect       Date:  2007-03-05       Impact factor: 2.451

Review 5.  Acute gastroenteritis in children : what role for antibacterials?

Authors:  Nopaorn Phavichitr; Anthony Catto-Smith
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Rotavirus gastroenteritis in children less than five years of age in primary care settings in Bulgaria: an observational study.

Authors:  Mayda Tiholova; Kusuma Gopala; Magda Berberova; Margarita Strokova-Stoilova; Monica Tafalla
Journal:  Germs       Date:  2016-09-01

7.  Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania.

Authors:  Ioana Alina Anca; Florentina Ligia Furtunescu; Doina Pleşca; Adrian Streinu-Cercel; Sorin Rugină; Katsiaryna Holl
Journal:  Germs       Date:  2014-06-02

8.  A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis.

Authors:  Stefanie Wildi-Runge; Simone Allemann; Urs B Schaad; Ulrich Heininger
Journal:  Eur J Pediatr       Date:  2009-02-11       Impact factor: 3.183

9.  Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study.

Authors:  Martin Sénécal; Marc Brisson; Marc H Lebel; John Yaremko; Richard Wong; Lee Ann Gallant; Hartley A Garfield; Darryl J Ableman; Richard L Ward; John S Sampalis; James A Mansi
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

10.  The health and economic burden of rotavirus disease in Belgium.

Authors:  Joke Bilcke; Pierre Van Damme; Frank De Smet; Germaine Hanquet; Marc Van Ranst; Philippe Beutels
Journal:  Eur J Pediatr       Date:  2008-03-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.